Pay in 4 interest-free payments of $6.49 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
Why prices stayed high: PBMs inflate list prices to increase their rebate Employers and insurers pay based on the inflated list price Patients pay the list price if uninsured Pharmas net price is much lower than the retail price The U.S
suitable for weekly dosing Safety Profile: Well tolerated
Additionally, in a Phase II clinical trial targeting a population with Metabolism-Associated Steatohepatitis (MASLD), treatment with 2.4 mg of pemvidutide for 24 weeks resulted in a relative liver fat content reduction of up to 76% as opposed to the placebo group's 14%
Understanding these metabolic effects has implications for research into diabetes and related metabolic conditions
US$ 24.63
US$ 22.87
US$ 25.35
US$ 27.89
US$ 28.59
US$ 29.79
US$ 23.82
